- Home
- MQ vs VCYT Comparison
MQ vs VCYT Comparison
Compare MQ & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MQ
- VCYT
- Stock Information
- Founded
- MQ 2010
- VCYT 2006
- Country
- MQ United States
- VCYT United States
- Employees
- MQ N/A
- VCYT N/A
- Industry
- MQ Computer Software: Prepackaged Software
- VCYT Medical Specialities
- Sector
- MQ Technology
- VCYT Health Care
- Exchange
- MQ Nasdaq
- VCYT Nasdaq
- Market Cap
- MQ 1.9B
- VCYT 2.1B
- IPO Year
- MQ 2021
- VCYT 2013
- Fundamental
- Price
- MQ $5.83
- VCYT $25.24
- Analyst Decision
- MQ Hold
- VCYT Buy
- Analyst Count
- MQ 13
- VCYT 9
- Target Price
- MQ $5.15
- VCYT $39.89
- AVG Volume (30 Days)
- MQ 5.9M
- VCYT 941.4K
- Earning Date
- MQ 08-06-2025
- VCYT 08-05-2025
- Dividend Yield
- MQ N/A
- VCYT N/A
- EPS Growth
- MQ N/A
- VCYT N/A
- EPS
- MQ 0.11
- VCYT 0.41
- Revenue
- MQ $528,100,000.00
- VCYT $463,393,000.00
- Revenue This Year
- MQ $19.30
- VCYT $12.55
- Revenue Next Year
- MQ $21.97
- VCYT $9.79
- P/E Ratio
- MQ $54.51
- VCYT $61.14
- Revenue Growth
- MQ N/A
- VCYT 23.42
- 52 Week Low
- MQ $3.37
- VCYT $19.73
- 52 Week High
- MQ $6.01
- VCYT $47.32
- Technical
- Relative Strength Index (RSI)
- MQ 58.45
- VCYT 35.63
- Support Level
- MQ $5.70
- VCYT $26.18
- Resistance Level
- MQ $6.01
- VCYT $27.91
- Average True Range (ATR)
- MQ 0.13
- VCYT 0.98
- MACD
- MQ -0.04
- VCYT -0.04
- Stochastic Oscillator
- MQ 42.86
- VCYT 1.09
About MQ Marqeta Inc.
Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.